nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—Embolism venous—Estradiol—osteoporosis	0.00937	0.00978	CcSEcCtD
Propericiazine—Galactorrhoea—Conjugated Estrogens—osteoporosis	0.00911	0.00951	CcSEcCtD
Propericiazine—Pulmonary embolism—Estropipate—osteoporosis	0.00894	0.00933	CcSEcCtD
Propericiazine—Pulmonary embolism—Raloxifene—osteoporosis	0.00866	0.00904	CcSEcCtD
Propericiazine—Menstruation irregular—Estradiol—osteoporosis	0.00854	0.00891	CcSEcCtD
Propericiazine—Amenorrhoea—Ethinyl Estradiol—osteoporosis	0.00825	0.00861	CcSEcCtD
Propericiazine—Deep vein thrombosis—Estradiol—osteoporosis	0.00777	0.00811	CcSEcCtD
Propericiazine—Galactorrhoea—Estradiol—osteoporosis	0.00729	0.00761	CcSEcCtD
Propericiazine—Photosensitivity—Alendronate—osteoporosis	0.00728	0.0076	CcSEcCtD
Propericiazine—Arrhythmia—Calcium Acetate—osteoporosis	0.00706	0.00737	CcSEcCtD
Propericiazine—Jaundice cholestatic—Conjugated Estrogens—osteoporosis	0.00672	0.00702	CcSEcCtD
Propericiazine—Amenorrhoea—Conjugated Estrogens—osteoporosis	0.00672	0.00702	CcSEcCtD
Propericiazine—Asthma—Etidronic acid—osteoporosis	0.00648	0.00677	CcSEcCtD
Propericiazine—Menorrhagia—Estradiol—osteoporosis	0.00639	0.00667	CcSEcCtD
Propericiazine—Pulmonary embolism—Conjugated Estrogens—osteoporosis	0.00591	0.00617	CcSEcCtD
Propericiazine—Confusional state—Calcium Acetate—osteoporosis	0.00566	0.00591	CcSEcCtD
Propericiazine—Oedema—Calcium Acetate—osteoporosis	0.00561	0.00586	CcSEcCtD
Propericiazine—Asthma—Estropipate—osteoporosis	0.00561	0.00585	CcSEcCtD
Propericiazine—Increased appetite—Ethinyl Estradiol—osteoporosis	0.0056	0.00584	CcSEcCtD
Propericiazine—Asthma—Alendronate—osteoporosis	0.00552	0.00577	CcSEcCtD
Propericiazine—Agranulocytosis—Etidronic acid—osteoporosis	0.00539	0.00563	CcSEcCtD
Propericiazine—Jaundice cholestatic—Estradiol—osteoporosis	0.00538	0.00562	CcSEcCtD
Propericiazine—Amenorrhoea—Estradiol—osteoporosis	0.00538	0.00562	CcSEcCtD
Propericiazine—Asthma—Ibandronate—osteoporosis	0.00538	0.00561	CcSEcCtD
Propericiazine—Hypotension—Calcium Acetate—osteoporosis	0.00525	0.00548	CcSEcCtD
Propericiazine—Weight increased—Estropipate—osteoporosis	0.0051	0.00533	CcSEcCtD
Propericiazine—Hyperglycaemia—Estropipate—osteoporosis	0.00506	0.00528	CcSEcCtD
Propericiazine—Photosensitivity reaction—Alendronate—osteoporosis	0.00504	0.00526	CcSEcCtD
Propericiazine—Dyskinesia—Estradiol—osteoporosis	0.00503	0.00525	CcSEcCtD
Propericiazine—Weight increased—Raloxifene—osteoporosis	0.00494	0.00516	CcSEcCtD
Propericiazine—Pneumonia—Raloxifene—osteoporosis	0.00487	0.00509	CcSEcCtD
Propericiazine—Pneumonia—Ibandronate—osteoporosis	0.00482	0.00503	CcSEcCtD
Propericiazine—Constipation—Calcium Acetate—osteoporosis	0.0048	0.00501	CcSEcCtD
Propericiazine—Pulmonary embolism—Estradiol—osteoporosis	0.00473	0.00493	CcSEcCtD
Propericiazine—Drowsiness—Calcitriol—osteoporosis	0.00469	0.0049	CcSEcCtD
Propericiazine—Hypokalaemia—Pamidronate—osteoporosis	0.00444	0.00463	CcSEcCtD
Propericiazine—Asthma—Risedronate—osteoporosis	0.00443	0.00463	CcSEcCtD
Propericiazine—Constipation—Ergocalciferol—osteoporosis	0.00424	0.00443	CcSEcCtD
Propericiazine—Gynaecomastia—Estradiol—osteoporosis	0.00423	0.00441	CcSEcCtD
Propericiazine—Cardiac disorder—Estropipate—osteoporosis	0.00417	0.00435	CcSEcCtD
Propericiazine—Hypersensitivity—Calcium Acetate—osteoporosis	0.00414	0.00432	CcSEcCtD
Propericiazine—Weight increased—Ethinyl Estradiol—osteoporosis	0.00414	0.00432	CcSEcCtD
Propericiazine—Angioedema—Etidronic acid—osteoporosis	0.00413	0.00431	CcSEcCtD
Propericiazine—Sweating increased—Pamidronate—osteoporosis	0.0041	0.00428	CcSEcCtD
Propericiazine—Hypokalaemia—Zoledronate—osteoporosis	0.00405	0.00423	CcSEcCtD
Propericiazine—Cardiac disorder—Raloxifene—osteoporosis	0.00404	0.00421	CcSEcCtD
Propericiazine—Cardiac disorder—Ibandronate—osteoporosis	0.00399	0.00417	CcSEcCtD
Propericiazine—Pneumonia—Risedronate—osteoporosis	0.00397	0.00415	CcSEcCtD
Propericiazine—Hypokalaemia—Conjugated Estrogens—osteoporosis	0.0039	0.00407	CcSEcCtD
Propericiazine—Asthma—Zoledronate—osteoporosis	0.00385	0.00402	CcSEcCtD
Propericiazine—Diarrhoea—Calcium Acetate—osteoporosis	0.00384	0.00401	CcSEcCtD
Propericiazine—Pneumonia—Pamidronate—osteoporosis	0.00378	0.00394	CcSEcCtD
Propericiazine—Nasal congestion—Estradiol—osteoporosis	0.00377	0.00393	CcSEcCtD
Propericiazine—Arrhythmia—Calcitriol—osteoporosis	0.00376	0.00393	CcSEcCtD
Propericiazine—Sweating increased—Zoledronate—osteoporosis	0.00375	0.00391	CcSEcCtD
Propericiazine—Confusional state—Etidronic acid—osteoporosis	0.00372	0.00388	CcSEcCtD
Propericiazine—Asthma—Conjugated Estrogens—osteoporosis	0.00371	0.00387	CcSEcCtD
Propericiazine—Infection—Etidronic acid—osteoporosis	0.00366	0.00382	CcSEcCtD
Propericiazine—Increased appetite—Estradiol—osteoporosis	0.00365	0.00381	CcSEcCtD
Propericiazine—Sweating increased—Conjugated Estrogens—osteoporosis	0.00361	0.00377	CcSEcCtD
Propericiazine—Angioedema—Estropipate—osteoporosis	0.00357	0.00373	CcSEcCtD
Propericiazine—Vomiting—Calcium Acetate—osteoporosis	0.00357	0.00373	CcSEcCtD
Propericiazine—Angioedema—Alendronate—osteoporosis	0.00352	0.00367	CcSEcCtD
Propericiazine—Agranulocytosis—Pamidronate—osteoporosis	0.00351	0.00366	CcSEcCtD
Propericiazine—Weight increased—Zoledronate—osteoporosis	0.0035	0.00366	CcSEcCtD
Propericiazine—Angioedema—Ibandronate—osteoporosis	0.00342	0.00357	CcSEcCtD
Propericiazine—Weight increased—Conjugated Estrogens—osteoporosis	0.00337	0.00352	CcSEcCtD
Propericiazine—Agitation—Calcitriol—osteoporosis	0.00337	0.00352	CcSEcCtD
Propericiazine—Hyperglycaemia—Conjugated Estrogens—osteoporosis	0.00334	0.00349	CcSEcCtD
Propericiazine—Nausea—Calcium Acetate—osteoporosis	0.00334	0.00348	CcSEcCtD
Propericiazine—Cardiac disorder—Risedronate—osteoporosis	0.00329	0.00344	CcSEcCtD
Propericiazine—Agranulocytosis—Zoledronate—osteoporosis	0.0032	0.00334	CcSEcCtD
Propericiazine—Oedema—Estropipate—osteoporosis	0.00319	0.00333	CcSEcCtD
Propericiazine—Arrhythmia—Risedronate—osteoporosis	0.00317	0.00331	CcSEcCtD
Propericiazine—Infection—Estropipate—osteoporosis	0.00317	0.00331	CcSEcCtD
Propericiazine—Constipation—Etidronic acid—osteoporosis	0.00315	0.00329	CcSEcCtD
Propericiazine—Cardiac disorder—Pamidronate—osteoporosis	0.00313	0.00327	CcSEcCtD
Propericiazine—Infection—Alendronate—osteoporosis	0.00312	0.00326	CcSEcCtD
Propericiazine—Dry mouth—Ibandronate—osteoporosis	0.00312	0.00326	CcSEcCtD
Propericiazine—Infection—Raloxifene—osteoporosis	0.00307	0.0032	CcSEcCtD
Propericiazine—Dry mouth—Calcitriol—osteoporosis	0.00305	0.00319	CcSEcCtD
Propericiazine—Infection—Ibandronate—osteoporosis	0.00304	0.00317	CcSEcCtD
Propericiazine—Hyperhidrosis—Raloxifene—osteoporosis	0.00299	0.00312	CcSEcCtD
Propericiazine—Asthma—Estradiol—osteoporosis	0.00297	0.0031	CcSEcCtD
Propericiazine—Hyperhidrosis—Ibandronate—osteoporosis	0.00296	0.00309	CcSEcCtD
Propericiazine—Nausea—Ergocalciferol—osteoporosis	0.00295	0.00308	CcSEcCtD
Propericiazine—Angioedema—Ethinyl Estradiol—osteoporosis	0.00289	0.00302	CcSEcCtD
Propericiazine—Sweating increased—Estradiol—osteoporosis	0.00289	0.00302	CcSEcCtD
Propericiazine—Insomnia—Estropipate—osteoporosis	0.00288	0.00301	CcSEcCtD
Propericiazine—Cardiac disorder—Zoledronate—osteoporosis	0.00286	0.00298	CcSEcCtD
Propericiazine—Somnolence—Estropipate—osteoporosis	0.00283	0.00296	CcSEcCtD
Propericiazine—Angioedema—Risedronate—osteoporosis	0.00282	0.00295	CcSEcCtD
Propericiazine—Insomnia—Raloxifene—osteoporosis	0.00279	0.00292	CcSEcCtD
Propericiazine—Insomnia—Ibandronate—osteoporosis	0.00277	0.00289	CcSEcCtD
Propericiazine—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.00275	0.00287	CcSEcCtD
Propericiazine—Arrhythmia—Zoledronate—osteoporosis	0.00275	0.00287	CcSEcCtD
Propericiazine—Constipation—Estropipate—osteoporosis	0.00273	0.00285	CcSEcCtD
Propericiazine—Hypersensitivity—Etidronic acid—osteoporosis	0.00272	0.00283	CcSEcCtD
Propericiazine—Insomnia—Calcitriol—osteoporosis	0.00271	0.00283	CcSEcCtD
Propericiazine—Photosensitivity reaction—Estradiol—osteoporosis	0.00271	0.00283	CcSEcCtD
Propericiazine—Weight increased—Estradiol—osteoporosis	0.0027	0.00282	CcSEcCtD
Propericiazine—Agitation—Pamidronate—osteoporosis	0.0027	0.00282	CcSEcCtD
Propericiazine—Constipation—Alendronate—osteoporosis	0.00269	0.0028	CcSEcCtD
Propericiazine—Angioedema—Pamidronate—osteoporosis	0.00268	0.0028	CcSEcCtD
Propericiazine—Hyperglycaemia—Estradiol—osteoporosis	0.00268	0.00279	CcSEcCtD
Propericiazine—Somnolence—Calcitriol—osteoporosis	0.00266	0.00278	CcSEcCtD
Propericiazine—Pneumonia—Estradiol—osteoporosis	0.00266	0.00278	CcSEcCtD
Propericiazine—Arrhythmia—Conjugated Estrogens—osteoporosis	0.00265	0.00277	CcSEcCtD
Propericiazine—Constipation—Ibandronate—osteoporosis	0.00262	0.00273	CcSEcCtD
Propericiazine—Oedema—Ethinyl Estradiol—osteoporosis	0.00258	0.0027	CcSEcCtD
Propericiazine—Jaundice—Estradiol—osteoporosis	0.00258	0.00269	CcSEcCtD
Propericiazine—Dry mouth—Risedronate—osteoporosis	0.00257	0.00268	CcSEcCtD
Propericiazine—Infection—Ethinyl Estradiol—osteoporosis	0.00257	0.00268	CcSEcCtD
Propericiazine—Constipation—Calcitriol—osteoporosis	0.00256	0.00267	CcSEcCtD
Propericiazine—Vision blurred—Zoledronate—osteoporosis	0.00253	0.00264	CcSEcCtD
Propericiazine—Diarrhoea—Etidronic acid—osteoporosis	0.00252	0.00263	CcSEcCtD
Propericiazine—Body temperature increased—Estropipate—osteoporosis	0.00252	0.00263	CcSEcCtD
Propericiazine—Tremor—Zoledronate—osteoporosis	0.00251	0.00262	CcSEcCtD
Propericiazine—Infection—Risedronate—osteoporosis	0.0025	0.00261	CcSEcCtD
Propericiazine—Body temperature increased—Alendronate—osteoporosis	0.00248	0.00259	CcSEcCtD
Propericiazine—Agitation—Zoledronate—osteoporosis	0.00246	0.00257	CcSEcCtD
Propericiazine—Angioedema—Zoledronate—osteoporosis	0.00245	0.00256	CcSEcCtD
Propericiazine—Body temperature increased—Raloxifene—osteoporosis	0.00244	0.00255	CcSEcCtD
Propericiazine—Vision blurred—Conjugated Estrogens—osteoporosis	0.00243	0.00254	CcSEcCtD
Propericiazine—Body temperature increased—Ibandronate—osteoporosis	0.00242	0.00252	CcSEcCtD
Propericiazine—Confusional state—Pamidronate—osteoporosis	0.00242	0.00252	CcSEcCtD
Propericiazine—Oedema—Pamidronate—osteoporosis	0.0024	0.0025	CcSEcCtD
Propericiazine—Infection—Pamidronate—osteoporosis	0.00238	0.00248	CcSEcCtD
Propericiazine—Body temperature increased—Calcitriol—osteoporosis	0.00237	0.00247	CcSEcCtD
Propericiazine—Angioedema—Conjugated Estrogens—osteoporosis	0.00236	0.00246	CcSEcCtD
Propericiazine—Hypersensitivity—Estropipate—osteoporosis	0.00235	0.00245	CcSEcCtD
Propericiazine—Vomiting—Etidronic acid—osteoporosis	0.00234	0.00245	CcSEcCtD
Propericiazine—Tachycardia—Pamidronate—osteoporosis	0.00234	0.00244	CcSEcCtD
Propericiazine—Rash—Etidronic acid—osteoporosis	0.00232	0.00243	CcSEcCtD
Propericiazine—Dermatitis—Etidronic acid—osteoporosis	0.00232	0.00242	CcSEcCtD
Propericiazine—Hyperhidrosis—Pamidronate—osteoporosis	0.00232	0.00242	CcSEcCtD
Propericiazine—Hypersensitivity—Alendronate—osteoporosis	0.00231	0.00242	CcSEcCtD
Propericiazine—Insomnia—Risedronate—osteoporosis	0.00228	0.00238	CcSEcCtD
Propericiazine—Hypersensitivity—Ibandronate—osteoporosis	0.00225	0.00235	CcSEcCtD
Propericiazine—Dyspnoea—Risedronate—osteoporosis	0.00225	0.00235	CcSEcCtD
Propericiazine—Hypotension—Pamidronate—osteoporosis	0.00224	0.00234	CcSEcCtD
Propericiazine—Dry mouth—Zoledronate—osteoporosis	0.00223	0.00233	CcSEcCtD
Propericiazine—Constipation—Ethinyl Estradiol—osteoporosis	0.00221	0.00231	CcSEcCtD
Propericiazine—Confusional state—Zoledronate—osteoporosis	0.00221	0.0023	CcSEcCtD
Propericiazine—Hypersensitivity—Calcitriol—osteoporosis	0.00221	0.0023	CcSEcCtD
Propericiazine—Cardiac disorder—Estradiol—osteoporosis	0.0022	0.0023	CcSEcCtD
Propericiazine—Nausea—Etidronic acid—osteoporosis	0.00219	0.00229	CcSEcCtD
Propericiazine—Oedema—Zoledronate—osteoporosis	0.00219	0.00228	CcSEcCtD
Propericiazine—Diarrhoea—Estropipate—osteoporosis	0.00218	0.00228	CcSEcCtD
Propericiazine—Infection—Zoledronate—osteoporosis	0.00217	0.00227	CcSEcCtD
Propericiazine—Insomnia—Pamidronate—osteoporosis	0.00217	0.00226	CcSEcCtD
Propericiazine—Constipation—Risedronate—osteoporosis	0.00216	0.00225	CcSEcCtD
Propericiazine—Diarrhoea—Alendronate—osteoporosis	0.00215	0.00224	CcSEcCtD
Propericiazine—Dyspnoea—Pamidronate—osteoporosis	0.00214	0.00223	CcSEcCtD
Propericiazine—Tachycardia—Zoledronate—osteoporosis	0.00214	0.00223	CcSEcCtD
Propericiazine—Somnolence—Pamidronate—osteoporosis	0.00213	0.00222	CcSEcCtD
Propericiazine—Hyperhidrosis—Zoledronate—osteoporosis	0.00212	0.00221	CcSEcCtD
Propericiazine—Diarrhoea—Raloxifene—osteoporosis	0.00211	0.00221	CcSEcCtD
Propericiazine—Oedema—Conjugated Estrogens—osteoporosis	0.00211	0.0022	CcSEcCtD
Propericiazine—Infection—Conjugated Estrogens—osteoporosis	0.00209	0.00219	CcSEcCtD
Propericiazine—Diarrhoea—Ibandronate—osteoporosis	0.00209	0.00218	CcSEcCtD
Propericiazine—Tachycardia—Conjugated Estrogens—osteoporosis	0.00206	0.00215	CcSEcCtD
Propericiazine—Constipation—Pamidronate—osteoporosis	0.00205	0.00214	CcSEcCtD
Propericiazine—Diarrhoea—Calcitriol—osteoporosis	0.00205	0.00214	CcSEcCtD
Propericiazine—Hypotension—Zoledronate—osteoporosis	0.00204	0.00213	CcSEcCtD
Propericiazine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00204	0.00213	CcSEcCtD
Propericiazine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00204	0.00213	CcSEcCtD
Propericiazine—Vomiting—Estropipate—osteoporosis	0.00203	0.00212	CcSEcCtD
Propericiazine—Rash—Estropipate—osteoporosis	0.00201	0.0021	CcSEcCtD
Propericiazine—Dermatitis—Estropipate—osteoporosis	0.00201	0.0021	CcSEcCtD
Propericiazine—Vomiting—Alendronate—osteoporosis	0.002	0.00208	CcSEcCtD
Propericiazine—Body temperature increased—Risedronate—osteoporosis	0.00199	0.00208	CcSEcCtD
Propericiazine—Rash—Alendronate—osteoporosis	0.00198	0.00207	CcSEcCtD
Propericiazine—Insomnia—Zoledronate—osteoporosis	0.00198	0.00207	CcSEcCtD
Propericiazine—Dermatitis—Alendronate—osteoporosis	0.00198	0.00207	CcSEcCtD
Propericiazine—Hypotension—Conjugated Estrogens—osteoporosis	0.00197	0.00206	CcSEcCtD
Propericiazine—Vomiting—Raloxifene—osteoporosis	0.00196	0.00205	CcSEcCtD
Propericiazine—Dyspnoea—Zoledronate—osteoporosis	0.00195	0.00204	CcSEcCtD
Propericiazine—Rash—Raloxifene—osteoporosis	0.00195	0.00203	CcSEcCtD
Propericiazine—Dermatitis—Raloxifene—osteoporosis	0.00195	0.00203	CcSEcCtD
Propericiazine—Somnolence—Zoledronate—osteoporosis	0.00195	0.00203	CcSEcCtD
Propericiazine—Vomiting—Ibandronate—osteoporosis	0.00194	0.00203	CcSEcCtD
Propericiazine—Tremor—Estradiol—osteoporosis	0.00194	0.00202	CcSEcCtD
Propericiazine—Rash—Ibandronate—osteoporosis	0.00193	0.00201	CcSEcCtD
Propericiazine—Dermatitis—Ibandronate—osteoporosis	0.00193	0.00201	CcSEcCtD
Propericiazine—Insomnia—Conjugated Estrogens—osteoporosis	0.00191	0.00199	CcSEcCtD
Propericiazine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.0019	0.00199	CcSEcCtD
Propericiazine—Vomiting—Calcitriol—osteoporosis	0.0019	0.00199	CcSEcCtD
Propericiazine—Agitation—Estradiol—osteoporosis	0.0019	0.00198	CcSEcCtD
Propericiazine—Nausea—Estropipate—osteoporosis	0.00189	0.00198	CcSEcCtD
Propericiazine—Body temperature increased—Pamidronate—osteoporosis	0.00189	0.00198	CcSEcCtD
Propericiazine—Angioedema—Estradiol—osteoporosis	0.00189	0.00197	CcSEcCtD
Propericiazine—Rash—Calcitriol—osteoporosis	0.00189	0.00197	CcSEcCtD
Propericiazine—Dermatitis—Calcitriol—osteoporosis	0.00189	0.00197	CcSEcCtD
Propericiazine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00188	0.00196	CcSEcCtD
Propericiazine—Somnolence—Conjugated Estrogens—osteoporosis	0.00187	0.00196	CcSEcCtD
Propericiazine—Constipation—Zoledronate—osteoporosis	0.00187	0.00195	CcSEcCtD
Propericiazine—Nausea—Alendronate—osteoporosis	0.00187	0.00195	CcSEcCtD
Propericiazine—Hypersensitivity—Risedronate—osteoporosis	0.00186	0.00194	CcSEcCtD
Propericiazine—Nausea—Raloxifene—osteoporosis	0.00183	0.00192	CcSEcCtD
Propericiazine—Nausea—Ibandronate—osteoporosis	0.00182	0.0019	CcSEcCtD
Propericiazine—Constipation—Conjugated Estrogens—osteoporosis	0.0018	0.00188	CcSEcCtD
Propericiazine—Nausea—Calcitriol—osteoporosis	0.00178	0.00186	CcSEcCtD
Propericiazine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00177	0.00185	CcSEcCtD
Propericiazine—Hypersensitivity—Pamidronate—osteoporosis	0.00177	0.00184	CcSEcCtD
Propericiazine—Body temperature increased—Zoledronate—osteoporosis	0.00173	0.00181	CcSEcCtD
Propericiazine—Diarrhoea—Risedronate—osteoporosis	0.00172	0.0018	CcSEcCtD
Propericiazine—Dry mouth—Estradiol—osteoporosis	0.00172	0.0018	CcSEcCtD
Propericiazine—Confusional state—Estradiol—osteoporosis	0.0017	0.00178	CcSEcCtD
Propericiazine—Oedema—Estradiol—osteoporosis	0.00169	0.00176	CcSEcCtD
Propericiazine—Infection—Estradiol—osteoporosis	0.00168	0.00175	CcSEcCtD
Propericiazine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00167	0.00174	CcSEcCtD
Propericiazine—Tachycardia—Estradiol—osteoporosis	0.00165	0.00172	CcSEcCtD
Propericiazine—Vomiting—Ethinyl Estradiol—osteoporosis	0.00164	0.00172	CcSEcCtD
Propericiazine—Diarrhoea—Pamidronate—osteoporosis	0.00164	0.00171	CcSEcCtD
Propericiazine—Hyperhidrosis—Estradiol—osteoporosis	0.00163	0.0017	CcSEcCtD
Propericiazine—Rash—Ethinyl Estradiol—osteoporosis	0.00163	0.0017	CcSEcCtD
Propericiazine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00163	0.0017	CcSEcCtD
Propericiazine—Hypersensitivity—Zoledronate—osteoporosis	0.00161	0.00168	CcSEcCtD
Propericiazine—Vomiting—Risedronate—osteoporosis	0.0016	0.00167	CcSEcCtD
Propericiazine—Rash—Risedronate—osteoporosis	0.00159	0.00166	CcSEcCtD
Propericiazine—Dermatitis—Risedronate—osteoporosis	0.00159	0.00166	CcSEcCtD
Propericiazine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00155	0.00162	CcSEcCtD
Propericiazine—Nausea—Ethinyl Estradiol—osteoporosis	0.00154	0.0016	CcSEcCtD
Propericiazine—Insomnia—Estradiol—osteoporosis	0.00153	0.00159	CcSEcCtD
Propericiazine—Vomiting—Pamidronate—osteoporosis	0.00152	0.00159	CcSEcCtD
Propericiazine—Rash—Pamidronate—osteoporosis	0.00151	0.00158	CcSEcCtD
Propericiazine—Dermatitis—Pamidronate—osteoporosis	0.00151	0.00158	CcSEcCtD
Propericiazine—Dyspnoea—Estradiol—osteoporosis	0.0015	0.00157	CcSEcCtD
Propericiazine—Somnolence—Estradiol—osteoporosis	0.0015	0.00157	CcSEcCtD
Propericiazine—Diarrhoea—Zoledronate—osteoporosis	0.0015	0.00156	CcSEcCtD
Propericiazine—Nausea—Risedronate—osteoporosis	0.0015	0.00156	CcSEcCtD
Propericiazine—Constipation—Estradiol—osteoporosis	0.00144	0.00151	CcSEcCtD
Propericiazine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00144	0.0015	CcSEcCtD
Propericiazine—Nausea—Pamidronate—osteoporosis	0.00142	0.00149	CcSEcCtD
Propericiazine—Vomiting—Zoledronate—osteoporosis	0.00139	0.00145	CcSEcCtD
Propericiazine—Rash—Zoledronate—osteoporosis	0.00138	0.00144	CcSEcCtD
Propericiazine—Dermatitis—Zoledronate—osteoporosis	0.00138	0.00144	CcSEcCtD
Propericiazine—Vomiting—Conjugated Estrogens—osteoporosis	0.00134	0.0014	CcSEcCtD
Propericiazine—Body temperature increased—Estradiol—osteoporosis	0.00133	0.00139	CcSEcCtD
Propericiazine—Rash—Conjugated Estrogens—osteoporosis	0.00133	0.00139	CcSEcCtD
Propericiazine—Dermatitis—Conjugated Estrogens—osteoporosis	0.00133	0.00139	CcSEcCtD
Propericiazine—Nausea—Zoledronate—osteoporosis	0.0013	0.00136	CcSEcCtD
Propericiazine—Nausea—Conjugated Estrogens—osteoporosis	0.00125	0.00131	CcSEcCtD
Propericiazine—Hypersensitivity—Estradiol—osteoporosis	0.00124	0.0013	CcSEcCtD
Propericiazine—Diarrhoea—Estradiol—osteoporosis	0.00115	0.0012	CcSEcCtD
Propericiazine—Vomiting—Estradiol—osteoporosis	0.00107	0.00112	CcSEcCtD
Propericiazine—Rash—Estradiol—osteoporosis	0.00106	0.00111	CcSEcCtD
Propericiazine—Dermatitis—Estradiol—osteoporosis	0.00106	0.00111	CcSEcCtD
Propericiazine—Nausea—Estradiol—osteoporosis	0.001	0.00105	CcSEcCtD
Propericiazine—ADRA1B—GPCR ligand binding—CALCR—osteoporosis	0.00036	0.00856	CbGpPWpGaD
Propericiazine—DRD1—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.000345	0.00821	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—WDR1—osteoporosis	0.000336	0.008	CbGpPWpGaD
Propericiazine—DRD1—G alpha (s) signalling events—ADCY5—osteoporosis	0.00033	0.00785	CbGpPWpGaD
Propericiazine—ADRA2A—Regulation of insulin secretion—ADCY5—osteoporosis	0.000327	0.00777	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.000323	0.00768	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.000319	0.00757	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—CALCR—osteoporosis	0.000297	0.00707	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—PTH1R—osteoporosis	0.000297	0.00707	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.000296	0.00703	CbGpPWpGaD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.000283	0.00672	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.000266	0.00633	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—CAP1—osteoporosis	0.000266	0.00632	CbGpPWpGaD
Propericiazine—ADRA2A—Integration of energy metabolism—ADCY5—osteoporosis	0.000257	0.00611	CbGpPWpGaD
Propericiazine—ADRA2A—G alpha (i) signalling events—CNR2—osteoporosis	0.000251	0.00598	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—CALCR—osteoporosis	0.000249	0.00591	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—PTH1R—osteoporosis	0.000249	0.00591	CbGpPWpGaD
Propericiazine—DRD1—G alpha (s) signalling events—POMC—osteoporosis	0.000243	0.00577	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.000242	0.00576	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.000241	0.00574	CbGpPWpGaD
Propericiazine—ADRA1B—Calcium Regulation in the Cardiac Cell—ADCY5—osteoporosis	0.000233	0.00555	CbGpPWpGaD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.000233	0.00555	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—PTH—osteoporosis	0.000231	0.00549	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CALCR—osteoporosis	0.000226	0.00537	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PTH1R—osteoporosis	0.000226	0.00537	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—CNR2—osteoporosis	0.000225	0.00535	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.00022	0.00522	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—WNT1—osteoporosis	0.000212	0.00503	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—MGLL—osteoporosis	0.000211	0.00502	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PTH1R—osteoporosis	0.000204	0.00484	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—CALCR—osteoporosis	0.000204	0.00484	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.0002	0.00475	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—MGLL—osteoporosis	0.000197	0.00469	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—ANXA2—osteoporosis	0.000193	0.00459	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—PLEK—osteoporosis	0.000193	0.00459	CbGpPWpGaD
Propericiazine—DRD1—Circadian rythm related genes—LEP—osteoporosis	0.000192	0.00457	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—PTHLH—osteoporosis	0.000191	0.00455	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—PTH—osteoporosis	0.000189	0.0045	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CALCR—osteoporosis	0.000185	0.00439	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PTH1R—osteoporosis	0.000185	0.00439	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—CNR2—osteoporosis	0.000184	0.00438	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—MGLL—osteoporosis	0.000179	0.00426	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—WNT1—osteoporosis	0.000173	0.00412	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—CALCA—osteoporosis	0.000169	0.00401	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CALCR—osteoporosis	0.000168	0.00399	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PTH1R—osteoporosis	0.000168	0.00399	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—TLN1—osteoporosis	0.000166	0.00396	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—VCL—osteoporosis	0.000164	0.0039	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—MGLL—osteoporosis	0.000162	0.00384	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—PTHLH—osteoporosis	0.000157	0.00373	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—PTH—osteoporosis	0.000156	0.00371	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PTH1R—osteoporosis	0.000153	0.00363	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CALCR—osteoporosis	0.000153	0.00363	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—CNR2—osteoporosis	0.000152	0.00362	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SOST—osteoporosis	0.000147	0.00351	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—MGLL—osteoporosis	0.000147	0.00349	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—WNT1—osteoporosis	0.000143	0.0034	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—CALCA—osteoporosis	0.000138	0.00328	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—RAP1A—osteoporosis	0.000137	0.00326	CbGpPWpGaD
Propericiazine—ADRA2A—G alpha (i) signalling events—ADCY5—osteoporosis	0.000134	0.00318	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—MGLL—osteoporosis	0.000133	0.00317	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CALCR—osteoporosis	0.000133	0.00317	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PTH1R—osteoporosis	0.000133	0.00317	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—PTH—osteoporosis	0.000131	0.0031	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—PTHLH—osteoporosis	0.000129	0.00308	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—CNR2—osteoporosis	0.000127	0.00303	CbGpPWpGaD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.000125	0.00297	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—FGA—osteoporosis	0.000124	0.00296	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—MGLL—osteoporosis	0.000121	0.00288	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SOST—osteoporosis	0.000121	0.00287	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PKM—osteoporosis	0.000119	0.00283	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—FDPS—osteoporosis	0.000119	0.00283	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PTH—osteoporosis	0.000119	0.00282	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000116	0.00275	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CNR2—osteoporosis	0.000116	0.00275	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—CALCA—osteoporosis	0.000114	0.00271	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—FGB—osteoporosis	0.000113	0.00269	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GPD2—osteoporosis	0.000113	0.00269	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PGLS—osteoporosis	0.000113	0.00269	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CALCR—osteoporosis	0.000109	0.0026	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PTH1R—osteoporosis	0.000109	0.0026	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—WNT1—osteoporosis	0.000109	0.00258	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—PTHLH—osteoporosis	0.000108	0.00257	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PTH—osteoporosis	0.000107	0.00254	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MGLL—osteoporosis	0.000106	0.00252	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—CNR2—osteoporosis	0.000104	0.00248	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—LRP5—osteoporosis	0.000103	0.00246	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PNP—osteoporosis	0.000103	0.00246	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ATIC—osteoporosis	0.000103	0.00246	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SOST—osteoporosis	9.96e-05	0.00237	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—IGF1—osteoporosis	9.94e-05	0.00236	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—LRP6—osteoporosis	9.89e-05	0.00235	CbGpPWpGaD
Propericiazine—ADRA2A—G alpha (i) signalling events—POMC—osteoporosis	9.84e-05	0.00234	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PTHLH—osteoporosis	9.82e-05	0.00234	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PTH—osteoporosis	9.71e-05	0.00231	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—CALCA—osteoporosis	9.52e-05	0.00226	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	9.48e-05	0.00225	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CNR2—osteoporosis	9.46e-05	0.00225	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CALCR—osteoporosis	9.01e-05	0.00214	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PTH1R—osteoporosis	9.01e-05	0.00214	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—WNT1—osteoporosis	8.9e-05	0.00212	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PTHLH—osteoporosis	8.86e-05	0.00211	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PTH—osteoporosis	8.82e-05	0.0021	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—POMC—osteoporosis	8.82e-05	0.0021	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—OXCT1—osteoporosis	8.78e-05	0.00209	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CA2—osteoporosis	8.78e-05	0.00209	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MGLL—osteoporosis	8.67e-05	0.00206	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CALCA—osteoporosis	8.65e-05	0.00206	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CNR2—osteoporosis	8.6e-05	0.00204	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—MGLL—osteoporosis	8.56e-05	0.00204	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—LRP5—osteoporosis	8.47e-05	0.00201	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TLN1—osteoporosis	8.35e-05	0.00199	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—LRP6—osteoporosis	8.1e-05	0.00193	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PTHLH—osteoporosis	8.04e-05	0.00191	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PTH—osteoporosis	8.01e-05	0.00191	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	7.83e-05	0.00186	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CNR2—osteoporosis	7.81e-05	0.00186	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—CALCA—osteoporosis	7.8e-05	0.00185	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—WNT1—osteoporosis	7.34e-05	0.00175	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PTHLH—osteoporosis	7.31e-05	0.00174	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—IDH2—osteoporosis	7.28e-05	0.00173	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—POMC—osteoporosis	7.22e-05	0.00172	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—P4HB—osteoporosis	7.2e-05	0.00171	CbGpPWpGaD
Propericiazine—DRD1—Circadian rythm related genes—IL6—osteoporosis	7.17e-05	0.00171	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MGLL—osteoporosis	7.16e-05	0.0017	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CALCA—osteoporosis	7.08e-05	0.00168	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PTH—osteoporosis	7e-05	0.00167	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—LRP5—osteoporosis	6.99e-05	0.00166	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—RAP1A—osteoporosis	6.88e-05	0.00164	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CYP27A1—osteoporosis	6.84e-05	0.00163	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TLN1—osteoporosis	6.84e-05	0.00163	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CNR2—osteoporosis	6.83e-05	0.00162	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—ADCY5—osteoporosis	6.77e-05	0.00161	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NFATC1—osteoporosis	6.71e-05	0.0016	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—LRP6—osteoporosis	6.68e-05	0.00159	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—DKK1—osteoporosis	6.66e-05	0.00158	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ACP5—osteoporosis	6.66e-05	0.00158	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PTHLH—osteoporosis	6.64e-05	0.00158	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CALCA—osteoporosis	6.44e-05	0.00153	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—WNT1—osteoporosis	6.42e-05	0.00153	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—FGA—osteoporosis	6.24e-05	0.00148	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—TPI1—osteoporosis	6.19e-05	0.00147	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—ADCY5—osteoporosis	6.15e-05	0.00146	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	5.96e-05	0.00142	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—POMC—osteoporosis	5.96e-05	0.00142	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—P4HB—osteoporosis	5.9e-05	0.0014	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CALCA—osteoporosis	5.85e-05	0.00139	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—P4HB—osteoporosis	5.82e-05	0.00138	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PTHLH—osteoporosis	5.8e-05	0.00138	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—BMP2—osteoporosis	5.8e-05	0.00138	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PTH—osteoporosis	5.74e-05	0.00136	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GAPDH—osteoporosis	5.71e-05	0.00136	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—FGB—osteoporosis	5.68e-05	0.00135	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TLN1—osteoporosis	5.64e-05	0.00134	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—RAP1A—osteoporosis	5.64e-05	0.00134	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CNR2—osteoporosis	5.59e-05	0.00133	CbGpPWpGaD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	5.56e-05	0.00132	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—RAP1A—osteoporosis	5.56e-05	0.00132	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—ADCY5—osteoporosis	5.55e-05	0.00132	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NFATC1—osteoporosis	5.5e-05	0.00131	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PSMA2—osteoporosis	5.48e-05	0.0013	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PSMA5—osteoporosis	5.48e-05	0.0013	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—DKK1—osteoporosis	5.46e-05	0.0013	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—WNT1—osteoporosis	5.26e-05	0.00125	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—IGF1—osteoporosis	5.13e-05	0.00122	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FGA—osteoporosis	5.11e-05	0.00122	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CALCA—osteoporosis	5.11e-05	0.00121	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—ADCY5—osteoporosis	5.04e-05	0.0012	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—POMC—osteoporosis	4.98e-05	0.00118	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—P4HB—osteoporosis	4.87e-05	0.00116	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PTHLH—osteoporosis	4.75e-05	0.00113	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—BMP2—osteoporosis	4.75e-05	0.00113	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PTH—osteoporosis	4.73e-05	0.00113	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—RAP1A—osteoporosis	4.65e-05	0.00111	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FGB—osteoporosis	4.65e-05	0.00111	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—KL—osteoporosis	4.64e-05	0.0011	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CNR2—osteoporosis	4.61e-05	0.0011	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—ADCY5—osteoporosis	4.58e-05	0.00109	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NFATC1—osteoporosis	4.54e-05	0.00108	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—POMC—osteoporosis	4.53e-05	0.00108	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—DKK1—osteoporosis	4.5e-05	0.00107	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ENO1—osteoporosis	4.5e-05	0.00107	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PSMA2—osteoporosis	4.49e-05	0.00107	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PSMA5—osteoporosis	4.49e-05	0.00107	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PSMA5—osteoporosis	4.43e-05	0.00105	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PSMA2—osteoporosis	4.43e-05	0.00105	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—IL6R—osteoporosis	4.41e-05	0.00105	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—WNT1—osteoporosis	4.34e-05	0.00103	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FGA—osteoporosis	4.22e-05	0.001	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CALCA—osteoporosis	4.18e-05	0.000995	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—ADCY5—osteoporosis	4.16e-05	0.000989	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—POMC—osteoporosis	4.08e-05	0.00097	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	3.92e-05	0.000933	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—BMP2—osteoporosis	3.92e-05	0.000933	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FGB—osteoporosis	3.84e-05	0.000913	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—KL—osteoporosis	3.8e-05	0.000903	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—POMC—osteoporosis	3.71e-05	0.000881	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	3.71e-05	0.000881	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	3.71e-05	0.000881	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ADCY5—osteoporosis	3.63e-05	0.000864	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL6R—osteoporosis	3.61e-05	0.00086	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CYP19A1—osteoporosis	3.6e-05	0.000855	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SPP1—osteoporosis	3.52e-05	0.000836	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CALCA—osteoporosis	3.45e-05	0.000821	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	3.37e-05	0.000801	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IRS2—osteoporosis	3.18e-05	0.000756	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KL—osteoporosis	3.14e-05	0.000746	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—LEP—osteoporosis	3.11e-05	0.00074	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—TGFB1—osteoporosis	3.07e-05	0.000731	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—POMC—osteoporosis	3.06e-05	0.000727	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	2.98e-05	0.000709	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	2.98e-05	0.000708	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ESR1—osteoporosis	2.97e-05	0.000706	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ADCY5—osteoporosis	2.94e-05	0.000698	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GPX1—osteoporosis	2.93e-05	0.000696	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SPP1—osteoporosis	2.88e-05	0.000685	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IRS1—osteoporosis	2.78e-05	0.00066	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—MTHFR—osteoporosis	2.7e-05	0.000642	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—POMC—osteoporosis	2.67e-05	0.000636	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL6R—osteoporosis	2.61e-05	0.00062	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IRS2—osteoporosis	2.6e-05	0.000619	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IGF1—osteoporosis	2.57e-05	0.000611	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—LEP—osteoporosis	2.55e-05	0.000606	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	2.46e-05	0.000584	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ESR1—osteoporosis	2.43e-05	0.000578	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SPP1—osteoporosis	2.38e-05	0.000565	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IRS1—osteoporosis	2.27e-05	0.000541	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—POMC—osteoporosis	2.19e-05	0.000521	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—POMC—osteoporosis	2.16e-05	0.000514	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IRS2—osteoporosis	2.15e-05	0.000511	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL6R—osteoporosis	2.14e-05	0.000508	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IGF1—osteoporosis	2.11e-05	0.000501	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—LEP—osteoporosis	2.1e-05	0.0005	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ESR1—osteoporosis	2.01e-05	0.000477	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—IL6—osteoporosis	1.97e-05	0.000468	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IRS1—osteoporosis	1.88e-05	0.000446	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—POMC—osteoporosis	1.81e-05	0.00043	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL6R—osteoporosis	1.76e-05	0.000419	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IGF1—osteoporosis	1.74e-05	0.000413	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL6—osteoporosis	1.61e-05	0.000383	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MYC—osteoporosis	1.55e-05	0.000367	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TGFB1—osteoporosis	1.54e-05	0.000367	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL6—osteoporosis	1.33e-05	0.000316	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MYC—osteoporosis	1.27e-05	0.000301	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	1.26e-05	0.0003	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL6—osteoporosis	1.16e-05	0.000276	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MYC—osteoporosis	1.04e-05	0.000248	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	1.04e-05	0.000248	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL6—osteoporosis	9.51e-06	0.000226	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL6—osteoporosis	7.85e-06	0.000187	CbGpPWpGaD
